TACT earnings analysis
What we found in TACT's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
TransAct delivered a modest revenue beat at $13.948 million and reported diluted EPS of $0.00, while gross margin improved 2.0 percentage points year over year to 50.2%. FST recurring revenue and BOHA! units grew 13% and 33%, respectively, although total revenue remained 0.4% below the prior-year quarter and casino sales declined. Management reiterated 2026 revenue guidance of $55 million-$57 million and raised adjusted EBITDA guidance to $1.5 million-$2.0 million; the 10-Q reported no material changes to the risk factors in the 2025 Form 10-K.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Beat and EPS Improved
- Second-quarter revenue was $13.948 million, approximately 1.8% above the $13.7 million estimate and 0.4% below $14 million in the prior-year quarter. Diluted EPS was $0.00 versus $(0.01) in the prior-year quarter and the $(0.01) estimate.
- Gross Margin Expanded
- Gross margin expanded to 50.2% from 48.2% in the prior-year quarter, a 2.0 percentage-point improvement.
- FST Recurring Revenue Grew
- FST recurring revenue increased 13% year over year, supporting the company’s recurring-revenue strategy.
- BOHA! Units Grew 33%
- BOHA! unit sales increased 33% year over year, indicating continued adoption of the company’s cloud-connected food-service platform.
- Revenue Reiterated; EBITDA Raised
- The company reiterated 2026 revenue guidance of $55 million-$57 million and raised adjusted EBITDA guidance to $1.5 million-$2.0 million.
- Share Repurchase Program Authorized
- The board authorized a $3.0 million share repurchase program effective May 12, 2026, although no shares were repurchased during the quarter ended June 30, 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Reported Sales Remained Below Prior Year
- Revenue of $13.948 million was 0.4% below the $14 million prior-year level, reflecting pressure in reported sales despite growth in FST recurring revenue and BOHA! units.
- Casino and Tariff Headwinds
- Casino sales declined year over year, and the prior earnings disclosure identified tariff refunds as reducing reported sales; the filing materials do not quantify either impact.
- Potential Cash Use for Repurchases
- The company authorized up to $3.0 million for share repurchases while no shares were repurchased in the quarter ended June 30, 2026; future repurchases could use cash that might otherwise support operations or investment.
- No Material Risk-Factor Update
- Management stated that there were no material changes to the risk factors disclosed in the 2025 Form 10-K, leaving the previously disclosed risks applicable.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.0
- Gross margin
- 50.2%
- Segment
- Food Service Technology (FST) recurring revenue grew 13% year over year.
- Segment
- BOHA! unit sales grew 33% year over year.
- Segment
- Casino sales declined year over year; the filing materials do not provide a quantitative decline percentage.
What they said about what is next.
2026 revenue guidance was reiterated at $55 million-$57 million. Adjusted EBITDA guidance was raised to $1.5 million-$2.0 million; the prior adjusted EBITDA range was not disclosed. No numeric EPS guidance was provided.
The filing reads better than the one before it.
What came before.
- 10-Q · May 13, 2026
- TransAct Technologies (TACT) reported a strong Q1 2026 performance, with revenues reaching $14.4 million, exceeding expectations of $12.6 million and reflecting a 10% year-over-year growth. For the quarter, the company…
- 10-K · March 12, 2026
- TransAct (TACT) is positioning to control and self-host its BOHA! foodservice software after acquiring a perpetual copy of the BOHA! source code for $2.55 million (plus ~ $1.0 million of transition professional…
- 10-Q · November 13, 2025
- TransAct reported a clear sequential and year-over-year improvement in Q3 2025: net sales rose to $13,176,000 (Q3 2024: $10,867,000), gross margin expanded to 49.8% and the company swung to a small operating profit of…
- 10-Q · August 12, 2025
- TransAct reported Q2 net sales of $13.798M (up $2.199M, +19.0% vs Q2 2024) with gross profit of $6.652M but a compressed gross margin of 48.2% (down from 52.7%). Operating loss narrowed to $(258)K (vs $(438)K) and…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing TACT makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever